<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03422250</url>
  </required_header>
  <id_info>
    <org_study_id>GR-2011-02349787</org_study_id>
    <nct_id>NCT03422250</nct_id>
  </id_info>
  <brief_title>Non-invasive Stimulation of Brain Networks and Cognition in Alzheimer's Disease and Frontotemporal Dementia</brief_title>
  <acronym>NetCogBs</acronym>
  <official_title>A Non-invasive, Multimodal Approach to Restore Functional Networks and Cognition in Alzheimer's Disease and Frontotemporal Dementia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Centro San Giovanni di Dio Fatebenefratelli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Centro San Giovanni di Dio Fatebenefratelli</source>
  <brief_summary>
    <textblock>
      This pilot study aims to test clinical and connectivity changes following non-invasive
      stimulation of disease-specific networks in Alzheimer's disease (AD) and behavioral variant
      frontotemporal dementia (bvFTD). Brain network stimulation will be carried out with
      transcranial direct current stimulation (tDCS). Target networks will be the default mode
      network (DMN) and salience network (SN). Twenty AD and 20 bvFTD patients will be recruited
      and assessed with a comprehensive clinical, behavioral and cognitive battery, and 3T MRI scan
      (including resting-state fMRI, arterial spin labeling, diffusion tensor imaging, structural
      MRI) at three time-points: baseline, after tDCS, and after 6 months. Patients will be
      randomized to 2 arms: anodal stimulation of the disease-specific network (DMN in AD, SN in
      bvFTD) or cathodal stimulation of the anti-correlated network (SN in AD, DMN in bvFTD). The
      intervention will consist of 10 tDCS sessions over two weeks. CSF samples will be collected
      at baseline for biomarker's assessment; blood samples will be collected at each time-point to
      assess changes in peripheral inflammatory markers. Blood and CSF collection will be optional.
      A sample of 20 elderly controls will be included for baseline comparisons.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 19, 2015</start_date>
  <completion_date type="Anticipated">November 3, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 3, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in clinical disease severity</measure>
    <time_frame>Baseline, post tDCS (week 3)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in behavioral symptom severity</measure>
    <time_frame>Baseline, post tDCS (week 3)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in functional connectivity</measure>
    <time_frame>Baseline, post tDCS (week 3)</time_frame>
    <description>Network functional connectivity on resting state fMRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in perfusion</measure>
    <time_frame>Baseline, post tDCS (week 3)</time_frame>
    <description>Network perfusion on arterial spin labeling</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in cognition: memory</measure>
    <time_frame>Baseline, post tDCS (week 3)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in cognition: language</measure>
    <time_frame>Baseline, post tDCS (week 3)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in cognition: executive function</measure>
    <time_frame>Baseline, post tDCS (week 3)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in cognition: visuospatial function</measure>
    <time_frame>Baseline, post tDCS (week 3)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in cognition: emotion recognition</measure>
    <time_frame>Baseline, post tDCS (week 3)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in structural connectivity</measure>
    <time_frame>Baseline, post tDCS (week 3)</time_frame>
    <description>Network structural connectivity on diffusion tensor imaging</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Alzheimer Disease</condition>
  <condition>Frontotemporal Dementia, Behavioral Variant</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anodal tDCS of disconnected networks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cathodal tDCS of hyper-connected networks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation (tDCS)</intervention_name>
    <description>10 daily 25-minutes tDCS sessions over two weeks. AD: Anodal tDCS of the default mode network (inferior parietal cortex). bvFTD: Anodal tDCS of the salience network (prefrontal cortex).</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation (tDCS)</intervention_name>
    <description>10 daily 25-minutes tDCS sessions over two weeks. AD: Cathodal tDCS of the salience network (prefrontal cortex). bvFTD: Cathodal tDCS of the default mode network (inferior parietal cortex).</description>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of AD or bvFTD according to current clinical criteria (Albert et al., 2011;
             Rascovsky et al., 2011)

          -  Ability to provide written informed consent

          -  Availability of a collateral source

        Exclusion Criteria:

          -  Moderate/severe dementia

          -  Presence of any medical or psychiatric illness that could interfere in completing
             assessments

        Exclusion Criteria for MRI and tDCS:

          -  metal implants, pace-makers, prosthetic heart valves

          -  claustrophobia

          -  history of epilepsy

          -  pregnancy

        Exclusion Criteria for controls:

          -  Current or past history of clinical, neurological, or psychiatric conditions that
             could interfere with the assessment (e.g., transient ischemic attack, ictus, head
             trauma, epilepsy, multiple sclerosis, neuropathy, mood disorders, substance abuse)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michela Pievani, PhD</last_name>
    <phone>+39 030 3501311</phone>
    <email>mpievani@fatebenefratelli.eu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lorenzo Pini</last_name>
    <phone>+39 030 3501563</phone>
    <email>lpini@fatebenefratelli.eu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IRCCS Centro San Giovanni di Dio Fatebenefratelli</name>
      <address>
        <city>Brescia</city>
        <zip>25125</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michela Pievani, PhD</last_name>
      <phone>+39 030 3501311</phone>
      <email>mpievani@fatebenefratelli.eu</email>
    </contact>
    <investigator>
      <last_name>Michela Pievani, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Pievani M, Pini L, Cappa SF, Frisoni GB. Brain networks stimulation in dementia: insights from functional imaging. Curr Opin Neurol. 2016 Dec;29(6):756-762. Review.</citation>
    <PMID>27661207</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2018</study_first_submitted>
  <study_first_submitted_qc>February 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2018</study_first_posted>
  <last_update_submitted>February 3, 2018</last_update_submitted>
  <last_update_submitted_qc>February 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Centro San Giovanni di Dio Fatebenefratelli</investigator_affiliation>
    <investigator_full_name>Michela Pievani</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Frontotemporal Dementia</mesh_term>
    <mesh_term>Aphasia, Primary Progressive</mesh_term>
    <mesh_term>Pick Disease of the Brain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

